Literature DB >> 17903926

Reperfusion enhances nitrotyrosine formation in rat focal cerebral ischemia.

Shunya Takizawa1, Naoto Fukuyama, Hisayuki Hirabayashi, Hiroe Nakazawa, Yukito Shinohara.   

Abstract

The widespread benefit of thrombolysis has been emphasized, but relatively little is known about reperfusion injury. The purpose of this study is to evaluate the difference in nitrotyrosine formation and infarct volume between permanent and transient focal ischemia in rats. Permanent (n = 14) or transient (n = 12) focal ischemia was induced by permanent or 2-hour occlusion of the middle cerebral artery, respectively, with the permanent ligation of the bilateral common carotid arteries in Sprague-Dawley rats. In both models all animals were killed 24 hours after the start of occlusion. The ratio of nitrotyrosine in the peri-infarct and core-of-infarct regions in transient focal ischemia was significantly higher than in permanent focal ischemia (P < .01). Infarct volume in the cortex, but not caudoputamen or whole brain, was significantly larger in transient ischemia than in permanent ischemia (P < .05), with a significant expansion of brain swelling. These results may reflect the higher production of superoxide and nitric oxide owing to reperfusion, and suggest the need to administer neuroprotective drugs such as anti-oxidants as well as thrombolytic agents in the treatment of acute ischemic cerebral damage.

Entities:  

Year:  2003        PMID: 17903926     DOI: 10.1016/S1052-3057(03)00074-0

Source DB:  PubMed          Journal:  J Stroke Cerebrovasc Dis        ISSN: 1052-3057            Impact factor:   2.136


  2 in total

1.  NADPH oxidase-2: linking glucose, acidosis, and excitotoxicity in stroke.

Authors:  Angela M Brennan-Minnella; Seok Joon Won; Raymond A Swanson
Journal:  Antioxid Redox Signal       Date:  2015-01-10       Impact factor: 8.401

2.  Sidenafil pre-treatment promotes decompression sickness in rats.

Authors:  Jean-Eric Blatteau; Alf O Brubakk; Emmanuel Gempp; Olivier Castagna; Jean-Jacques Risso; Nicolas Vallée
Journal:  PLoS One       Date:  2013-04-08       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.